米非司酮用于剖宫产后瘢痕子宫引产的临床效果观察  

Clinical effect of mifepristone for induction of labor in scar uterus after cesarean section

作　　者：黄慧 HUANG Hui(Dayu County People's Hospital,Jiangxi Province,Ganzhou City 341500,China)

机构地区：[1]江西省大余县人民医院

出　　处：《临床合理用药杂志》2019年第35期22-23,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的观察米菲司酮应用于剖宫产后瘢痕子宫引产的临床效果。方法选取医院收治的瘢痕子宫妊娠患者160例,随机分为观察组和对照组,每组80例。对照组给予依沙丫啶引产,观察组则在引产前服用米非司酮,随后再行依沙丫啶引产,比较2组引产成功率、产后出血情况、引产时间、产道损伤情况。结果观察组引产成功率高于对照组,产道损伤率低于对照组,产后出血量少于对照组,引产时间短于对照组(P均<0. 01)。结论剖宫产后瘢痕子宫引产中应用米非司酮可有效提高引产成功率,产后出血量少,缩短引产时间,降低产道损伤发生率,具有较高应用价值。Objective To observe the clinical effect of mifepristone in the induction of labor in scar uterus after cesarean section. Methods A total of 160 patients with scarred uterine pregnancy were selected and randomly divided into observation group and control group,with 80 cases in each group. The control group was given ethacridine for induction of labor,and the observation group was given mifepristone before induction of labor,and then was given ethacridine for induction of labor. The labor induction success rate,postpartum hemorrhage,induction labor time,and birth canal injury were compared between the two groups. Results The success rate of induction of labor in the observation group was higher than that of the control group,and the rate of birth canal injury was lower than that of the control group( P < 0. 01). Conclusion The application of mifepristone in the induction of labor in scar uterus after cesarean section can effectively improve the success rate of labor induction,reduce the amount of postpartum hemorrhage,shorten the induction time and reduce the risk of birth canal injury. Has higher application value.

关 键 词：米非司酮 依沙丫啶 剖宫产后瘢痕子宫 引产 临床疗效 

分 类 号：R719.3[医药卫生—妇产科学]